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ABSTRACT 
 
Modulation of the Endothelial Phenotype by Transitional Growth Factor-β2 and Nck Signaling  
 
Thao-Nguyen Pham 
Department of Biology 
Department of Wildlife and Fisheries Science 
Texas A&M University 
 
Research Advisor: Dr. Gonzalo Rivera 
Department of Veterinary Pathobiology 
Texas A&M University 
 
The development of solid tumors requires neovascularization. In contrast to blood vessels 
of healthy organs, blood vessels associated with atherosclerosis and tumors are poorly organized 
and leaky. However, it is poorly understood how microenvironmental factors modulate 
molecular mechanisms underlying the abnormal vascular phenotype. The objective in this project 
is to determine cellular changes elicited by transforming growth factor-β2 (TGF-β2) and the Nck 
adaptors in the transition of endothelial sheets from a stable/cohesive to a loosely organized, 
permeable phenotype.  It is hypothesized that the Nck adaptors link heightened matrix stiffness 
and TGF-β2 signaling thereby inducing cytoskeletal changes underlying the tumor-associated 
endothelial phenotype.  Cell culture experiments coupled with immunofluorescence labeling 
indicate change in cell morphology and patterns of protein expression/subcellular distribution 
when TGF-β2-treated cells were compared with control endothelial cells. Preliminary results 
indicate the Nck modulates TGF-beta-induced changes in cell morphology. These results suggest 
that the TGF-β2 signaling pathway and/or the silencing of the Nck could be targeted to prevent 
Endothelial to Mesenchymal Transition (EndMT) and the abnormal vasculature in 
atherosclerosis.  
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NOMENCLATURE  
 
AHA                American Heart Association  
EndMT Endothelial Mesenchymal Transition  
HUVEC Human Umbilical Vein Endothelial Cells 
PEG   Polyethylene glycol hydrogels  
SM22-α smooth muscle 22  
TGF-β2 Transforming Growth Factor - Beta 2 
VE-Cad VE-Cadherin 
VEGF            Vascular Endothelial Growth Factor 
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CHAPTER I 
INTRODUCTION 
 
Significance 
The American Heart Association (AHA) states that atherosclerosis is one of the leading 
causes of vascular disease worldwide (Momiyama 2014). When the blood vessels narrow due to 
plaque formation in the artery wall, it increases blood pressure by forcing the heart to pump 
blood faster through the arteries due to the decreased diameter of the vessel walls. This increases 
the risk of a stroke or heart attack.  At a cellular level, we hypothesize that plaque formation is 
promoted by endothelial cells transitioning into mesenchymal cells.  
 
Figure 1. EndMT is linked to plaque development. As endothelial cells take on a 
mesenchymal phenotype, risk of plaque development increases. 
Endothelial cells make up the lining of blood vessels, express apical-basal polarity, and 
have a cobblestone morphology as depicted in Figure 1. Their tight junctions and cell-to-cell 
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adhesions create a strong, yet permeable barrier. In contrast to the quiescent vasculature, 
endothelial cells experience phenotypic changes consistent with EndMT in vascular beds 
undergoing angiogenesis.  
 
Figure 2. Aortic geometry affects blood flow patterns. Laminar blood flow is disturbed 
at bifurcations. Disturbed flow activates ECs which contributes to EndMT. Red denotes rapid 
flow, blue, slower flow, and purple, disturbed flow. 
 The earliest stage of atherosclerosis is intimal stiffening ((Miroshnikova et al., 
2016). The stiffening of the matrix results in more TGF-β2 being released by the cells, 
eventually resulting in stiffer blood vessels, as demonstrated in the human carotid bifurcation in 
Figure 2. The blood flow in the outer region of the blood vessel is characterized as laminar flow, 
in contrast to the forked area where the vessel splits, where-in blood flow characterized as a 
disturbed flow (Miroshnikova et al., 2012).  The topography of the forked area results in blood 
hitting the side of the vessel, creating a circular, turbulent flow which explains why some areas 
in the human aorta are more susceptible to atherosclerosis than others (Miroshnikova et al., 
2012).  
The abnormal tumor vasculature contributes to tumor progression and metastasis 
(Miroshnikova et al., 2012). The leaky nature of the vasculature in solid tumors results in 
increased interstitial pressure and thereby decreased diffusion of anticancer drugs.  In addition, 
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the poor architectural organization of the tumor vasculature facilitates intravasation of invasive 
cancers cells and metastatic spread. Therapeutic strategies aimed at limiting the abnormal 
vascular growth in tumors, particularly targeting vascular endothelial growth factor (VEGF) 
signaling, have shown limited effectiveness. Unfortunately, the development of resistance to 
such therapies has been linked to tumor relapse and disease progression (Jung et. Al.,2017 ; 
Rigamonti et al., 2014). Thus, a better understanding of cellular and molecular mechanisms 
underlying tumor angiogenesis holds promise for the development of new and improve anti-
cancer treatments.  
Scientific Premise 
  Emerging evidence suggests that, under conditions prevalent in the tumor 
microenvironment, vascular endothelial sheets undergo a phenotypic switch from a 
stable/cohesive state to a mesenchymal-like state characterized by altered cell-cell junctional 
organization and increased permeability (Millan et al., 2010). Within the tumor 
microenvironment, matrix stiffening (Miroshnikova et al., 2016) and increased TGF-β2 signaling 
(Liu et al., 2012) are critical cues promoting a tumor vascular phenotype.   
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Approach 
 
Figure 3. TGF-β2 activates the Smad pathway. Phosphorylated Smad 2 and 3 form a complex 
with Smad 4 in the cytosol and travel to the nucleus to alter gene transcription. 
 Figure 3 shows a diagram of TGF-β2 and its hypothesized effect. TGF-β2, the primary 
signal molecule for EndMT, phosphorylates SMAD 2 and 3. The SMAD forms a heterotrimeric 
complex with SMAD 4, and travel from cytosol to nucleus, where they alter gene expression 
(Cooley et al., 2014). This results in a down-regulation of endothelial genes, and an upregulation 
of mesenchymal genes, which via transcription and translation produce proteins that with 
immunofluorescent staining and confocal imaging can be observed and quantified (Chen et al., 
2015a).  
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One main consequence of EndMT is altered integrity of the endothelial barrier as a result 
of partial disassembly of cell-to-cell adhesions. The intensity and distribution of the VE-
Cadherin (VE-Cad) marker will be measured to quantify the effect of TGF-β2 (Erasmus et al., 
2016). The decrease in VE-Cad in cells treated with TGF-β2 is expected. Furthermore, the 
decrease in the endothelial marker CD31 at the junctions between cells will denote EndMT. The 
two mesenchymal markers, Vimentin and SM22-α, are both expected to have an upregulation in 
cells treated with TGF-β2.  Vimentin is an intermediate filament and SM22-α is smooth muscle 
actin protein. The overall cytoskeleton organization will be assessed by labeling F-actin 
(Erasmus et al., 2016). 
Research Design  
To monitor and detect EndMT progression, we used immunofluorescence staining with 
specific antibodies for each endothelial and mesenchymal marker (Chen et al., 2015a). This will 
create a visual image of the HUVEC cells fixed after TGF-β2 induction, allowing the 
architectural integrity of the cell to be assessed overall (Baumgartner et al., 2003). Table 1, 2, 
and 3 denotes the general timeline of each experiment performed in these experiments. 
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CHAPTER II 
METHODS 
 
in vitro cell culturing 
 HUVEC cells were all frozen at passage 5 (P5) and were then thawed to room 
temperature. They were plated with either complete media or starvation media in a 10 cm 
fibronectin coated plate. Fresh media was added after 24 hours to remove any dead or unattached 
cells. Subsequently, fresh media was changed every other day until 50% confluence. 
in vitro Induction of EndMT 
 
Figure 4. A representation of the 12-well plate used in Experiment 1 and Experiment 2.  
 At passage 6, the cells were seeded at a density of 7.5 x 104 cells/cm2 onto a fibronectin 
coated coverslip placed inside each well of a 12-well plate as denoted in Figure 4. After 24 
hours, half of the wells received either complete media or starve media with TGFβ-2 and the 
other half received only complete media or starve media (Table 1). The non-induced cells were 
used as the control. 
 Treatment with TGF-beta and washing steps of immunofluorescence were performed in 
the wells. Coverslips were removed during the blocking/IF steps and mounted on a microscope 
coverslip with Prolong Gold (Appendix A). 
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Table 1. Timeline overview of the protocol performed for Experiments 1-2 
 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 
Experiment 
1 
Plate cells 
onto 10 cm 
plate 
Change  
complete 
media 
Pass cells onto 
coverslips 
Add TGF-β2 
to half of the 
wells  
Add TGF-β2 to 
half of the 
wells 
Fix and 
probe 
Experiment 
2 
Plate cells 
onto 10 cm 
Change starve 
media 
Pass cells onto 
coverslips 
Add TGF-β2 
to half of the 
wells 
Add TGF-β2 to 
half of the 
wells 
Fix and 
Probe 
Note: Antibodies probed are listed in the methods, Appendix A, and are discussed in the results 
siRNA and siNck-mediated silencing  
 HUVEC cells at P5 and P3 were cultured on 10 cm plates, then at 90% confluence cells 
were passed into fibronectin-coated 6-well plates with a plating density of 20 x 104cells/cm2. 
After 24 hours, the complete media was changed to antibiotic free serum in preparation for the 
transfection procedure. 
Table 2. Dilutions preparation of siRNA with antibiotic-free complete media.  
 
Plating 
Format 
 
Surface Area 
(cm2/well)  
Tube 1: diluted siRNA 
(µl/well) 
Tube 2: diluted DharmaFECT 
(µl/well)  
Volume of 
5uM siRNA 
(µl) 
Serum-free 
Medium (µl) 
Volume of 
DharamaFECT4 
reagent (µl) 
Basal 
Medium (µl) 
6-well plate 
siNck 
10 Nck1: 10 
Nck2: 10 
160 4 196 
6-well plate 
siScr 
10 10 190 4 196 
 
 The transfection method was modified from previous research (Pils et al., 2012). 
Dilutions of siRNA with basal media were prepared by combining diluted siRNA media with 
diluted DharmaFECT (Table 2). 
Table 3. Timeline of protocols performed for transfection followed by TGF-β treatment. 
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 
Plate 
cells 
onto 
10cm 
plate 
Change 
media 
(CM) 
Pass onto 
6-well 
plates  
siRNA; 
siNck 
knockdown 
Pass onto 
coverslips 
in 12-
well plate 
Add 
TGF-β2 
to half of 
wells  
Add 
TGF-β2 
to half of 
wells  
Fix and 
IF cells 
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 After the mixtures were added accordingly to each well, cells were incubated at 37°C for 
6 hours before the antibiotic-free media was replaced with complete media (Table 3).     
 
Figure 5. 12-well plate for Day 5 and Day 6 TGF-β2 treatment. 8 out of 12 wells were used in 
each plate. One plate was used each for VE-Cad and vimentin.  
After 24 hours of incubation with complete media, cells were collected on Day 5 and passed at 
7.5 x 104cells/cm2 to 16 total fibronectin coated coverslips followed by 24 and 48 hour TGF-β2 
treatments of siNck1, siNck 2, and siScr (Table 3, Figure 5, Appendix A).   
Immunofluorescence 
The immunofluorescence protocol was modified from previous research (Erasmus et al., 
2016) with different antibodies used for this study. At passage 7, 4% paraformaldehyde was used 
to fix the cells, followed by blocking in complete buffer (CB) and 2% Bovine Serum Albumin 
(BSA) (Appendix A).  
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Figure 6. Indirect immunofluorescence allows visualization of specific proteins. Primary 
antibodies bind specific proteins. Fluorescently labeled secondary antibodies bind to the primary 
based on species.  
The antibodies were incubated at room temperature for an hour with the following 
antibodies: VE-Cad (1:500, sc-9989), vimentin (1:500, sc-6260), f-actin phalloidin (1:200, REF 
T7471) and SM22α (1:500, ab14106) (Figure 6). Then was then followed by the secondary 
antibody blocking, at room temperature, with goat-anti mouse Alexa Fluor 488 (REF A11034) 
and goat-anti rabbit Alexa Fluor 647 (REF A11029)(Figure 6) (Appendix A). Prolong Gold was 
used to adhere the coverslip to a microscope slide. After 24 hours of storage in darkness, the 
mounted cells were imaged with a LSM780 confocal microscope at different wavelengths and 
planes. The images were later analyzed with ImageJ. 
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Fabrication of Hydrogels 
 
Figure 7. Fabrication of PEG-based hydrogels. Stiff (23 kPa) and soft (4.5 kPa) hydrogels are 
cured on 18 mm round coverslips using a UV mediated light source for 5 minutes. 
Future experiments will test how the synergism between matrix stiffness and TGF-β 
modulates the phenotype of HUVECs.  Polyethylene glycol hydrogels (PEG) coated with 
fibronectin to resemble the tumor microenvironment were designed with stiffness of normal 
tissue (~4.5 kPa) or tumor tissue (23 kPa) (Figure 7, Figure 8). The overall stiffness of the 
hydrogels increased with a decrease in mesh size and increase in concentration of the PEG-
compounds.  
 
Figure 8. Hydrogel composition. Both stiff and soft gels were made with 4-arm-PEG-
norbornene. B. For stiffer gels, 4-arm-PEG-tetra-thiol was added. C. For softer gels, PEG di-
thiol was added. 
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Endothelial cells plated on stiff and soft hydrogels will be left untreated (control) or 
treated with TGF-β2 at 24 hours and 48 hours. If results indicate significant morphological 
changes, deletion of the Nck gene and TGF-β2 treatment will also be tested to confirm the role of 
Nck in EndMT. 
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CHAPTER III 
RESULTS 
 
TGF-β2 induction of EndMT in HUVEC cells   
 
Figure 9. A and B in vitro immunostaining for endothelial and mesenchymal markers in 
HUVEC cells. Scale bar denotes 60 μm. In TGFβ-2 treated cultures, induction of EndMT is 
denoted from an upregulation of f-actin (phalloidin) stress fibers and a less cobblestone-like 
morphology. A.  Experiment 1: cells were cultured in complete media and (right) TGF-β2 
(10ng/mL). B.  Experiment 2: cells were cultured in starve media (0.2% serum) and (right) TGF-
β2 (10ng/mL).  
 TGF-β2 is one of the established pathways that regulates EndMT (Cooley et al., 2014). F-
actin, measured with phalloidin (red, Figure 9A), appeared the same in distribution and intensity 
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in both control and TGF-β2 treated.  However, the use of starvation media with TGF-β2 
remodeled the actin cytoskeleton matrix (Figure 9B). The increase in actin fibers was expected 
once the cells were induced with TGF-β2 and incubated in starve media. The increased 
expression of EndMT could also be from the addition of stress fibers, since the amount of stress 
fibers directly correlates to the stiffness of the cell. Further stiffening of the cell is another 
morphological change in EndMT (Liu et al., 2012). 
Fig 
Figure 10A and B. in vitro immunostaining for endothelial and mesenchymal markers in 
HUVEC cells. Scale bar denotes 60 μm. In TGFβ-2 treated cultures, induction of EndMT is 
denoted from an upregulation of SM22-α. VE-Cadherin intensity is reduced, indicated by thinner 
adhesions.  A.  Experiment 1: cells were cultured in complete media and (right) TGF-β2 
(10ng/mL). B.  Experiment 2: cells were cultured in starve media (0.2% serum) and (right) TGF-
β2 (10 ng/mL).  
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 There was a deregulation of VE-Cadherin in TGF-β2-treated HUVEC cells in both 
Figures 10A and 10B. The VE-Cad marker is distributed more in the cytoplasm of TGF-β2 
treated cells compared to the extracellular location in control cells. Overall, there are also thinner 
filaments in the TGF-β2 treated cells. Both indicate a disruption of endothelial cell-to-cell 
junctions, as endothelial cells lose their cobblestone-like shape and transition into narrow 
fibroblast shaped cells, consistent with a migratory phenotype.  
 The amount of vimentin was not noticeable difference between control and TGF-β2 
treated cells cultured in complete media (Figure 9A) or starve media (Figure  9B). This might be 
due to the homogenous stiffness from the coverslips. Further examination of the vimentin marker 
could be performed on soft and stiff hydrogels to compare the amount of intermediate 
mesenchymal filaments. SM22-⍺, a mesenchymal marker, is expected to show an upregulation in 
TGF-β2 induced cells. The results indicate there was no upregulation in SM22-⍺, when cultured 
in complete media. However, cells cultured in starve media show an is an increase in intensity of 
SM22-⍺, located on the stress fibers.  
 
Fig 11A. Immunostaining of in vitro HUVEC cells and EndMT markers, with the nucleus 
stained blue. Scale bar denotes 60 μm. Both IgG mouse and IgG rabbit antibodies were used as 
isotype control.  
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 The signals in the cytoplasm appear to be background noises as denoted in Figure 11A 
with IgG rabbit antibody. The overall change in the appearance of the cells is an indicator of 
EndMT. The cells start to lose their cobblestone-like shape and transform into spindle-shaped, 
fibroblast-like shape when induced by TGF-β2.  The endothelial phenotype is affected by the 
TGF-β2 pathway as endothelial markers are gradually decreasing when mesenchymal markers 
are increasing. The switch from the stable/cohesive phenotype to a tumor-like state reflects 
previous research (Millan et al., 2010).  
Effect of silencing Nck adaptor proteins and TGF-β2 treatment 
 
Figure 12) A. Nck deletion affects cell morphology. B. Analysis of Western Blots. Results 
indicate a reduction in the amount of siNck protein present after the transfection procedure. 
 To serve as a baseline, experimentation was performed several times to determine that 
TGF-β2 induced EndMT in this lab. Overall, the group of cells treated with TGF-β2 appear to be 
more elongated, a sign of endothelial to mesenchymal transition (Figure 12). The Western Blot 
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results indicate that there was an equal loading of GAPDH, siRNA, and siNck. The decrease in 
Nck protein indicates the transfection procedure successfully knocked down the Nck gene in the 
HUVECs (Figure 12B). The immunostaining results visually parallel the Western Blot results 
with the differing intensity of vimentin and f-actin (Figure 12A). Between the control and siNck 
group, the cells in the control group have a more specific intensity of F-actin at the cellular 
membrane (Figure 12).  
 
 
Figure 13A. Nck deletion attenuates vimentin upregulation. B. Nck deletion lowers F-Actin 
levels. 
 Presented in Figure 12, the intensity of fibers expressed is highest in control cells treated 
with TGF-β2, indicating that knocking down the Nck genes alter cytoskeleton formation while 
silencing RNA did not interfere with cellular function. Based on preliminary findings, deletion of 
Nck in HUVECs alters their phenotype and morphology, suggesting that Nck plays a role in the 
connection between TGF-β2 and the production of stress fibers.  
 Between control and Nck-silenced cells, there is a higher concentration of vimentin 
clustered closer to the nucleus in the former than latter (Figure 13). This contrasts with the Nck-
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silenced group, where vimentin appears to be clustered closer to the plasma membrane. These 
results may indicate that cells in the control group have a more migratory phenotype.  
 Both the immunostaining and Western Blot results demonstrate that silencing the Nck 
genes can reduce the progression of EndMT in HUVEC cells.  
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CHAPTER IV 
CONCLUSIONS 
  
 Atherosclerosis and many cancers promote angiogenesis which results in leaky, poorly 
perfused vasculature, that decreases blood vessel integrity and promotes rapid proliferation and 
metastasis for tumor (Chen et al., 2015a). The endothelial to mesenchymal transition is a major 
step in promotion of abnormal tumor vasculature, as it disrupts the cells that line blood vessels. 
The vascular endothelial cells under certain stressful environment with TGF-β2 signaling 
molecule can undergo a switch in phenotype from endothelial to a more mesenchymal-like 
morphology (Cooley et al., 2014). In this study, the induction of TGF-β2 to HUVECs resulted in 
a downregulation of VE-Cadherin thereby decreasing cell-to-cell junctions. As the endothelial 
cells morph into fibroblast-like cells, they downregulate their VE-Cadherin expression, and 
express more stress fibers (f-actin).  
 In this research study, the role played by the Nck family of adaptor proteins, known to 
facilitate cytoskeletal remodeling, was better defined. A baseline was established; in the presence 
of TGF-β2 signaling molecule there was a shift in HUVEC phenotype. Results following this 
establishment indicate that Nck seems to attenuate this shift in phenotype when compared to the 
control. I plan to repeat this experimental design in order to collect more data to support this 
hypothesis.  
 These findings are significant because development of angiogenesis drugs that target the 
TGF-β2 pathway, or cause reversal of TGF-β2 induced changes can reduce abnormal 
development of the vascular system, increase the profusion of cancer drugs to the cancer cells, 
and decrease the chances of malignancy.  
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APPENDIX 
REAGENTS USED FOR THE EXPERIMENTS 
 
Table 4. Reagents used to culture and harvest cells  
Process Reagent Vendor Catalogue number 
Preparation for FN-
coated coverslips 
18 mm round coverslips VWR- Vista Vision 16004 - 300 
Fibronectin  
(100 μg/μL) Millipore 341635 
Cell Culture and 
Passing 
EGM2 Bullet kit  
(EBM2 Basal Media + 
growth factors) 
Lonza CC-3162 
HUVEC  LN2 R4B2 
Trypsin/EDTA 
(0.25mg/mL) Lonza CC5012 
Phosphate Buffered 
Saline (PBS) Gibco - Invitrogen 10010-013 
3% FBS in PBS 
(Phosphate Buffered 
Saline) 
FBS – Nalgene CC-4101A 
Induction of 
EndoMT via TGF-
β2 stimulation 
10 ng /mL TGF-β2 
Stock 20 ng/µL Gibco - Invitrogen PH 69114 
Endothelial 
starvation 
media w/ 0.2 
% FBS 
 
 
EBM2 
Basal 
Media 
Lonza 
 
CC-3162 
 
 
FBS Lonza CC-4101A 
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Table 5. Reagents used for immunofluorescence staining 
Step Materials:  Mixed compound / stock solution 
Stock Solution 
Company 
Catalog 
Number 
Fixing 
4% 
Paraformaldehyde 
in DPBS 
  
16 % 
Paraformaldehyde 
Electron 
Microscopy 
Sciences 
Cat # 15710 
PBS 1X Gibco - Invitrogen 10010 - 031 
Blocking 
0.2% Triton X-
100 in CB Triton
TM X-100 VWR International VW 3929-2 
2% BSA in CB BSA Fisher Bio Reagents  
CAS 9048-46-
8 
Primary 
Dilution 
WhatmanTM Chromatography Paper NuPAGE® 3030-6188 
CD31 Abcam ab 28364 
SM22-α Abcam  ab 14106 
VE-Cadherin Santa Cruz sc -9989 
Vimentin Santa Cruz sc - 6260 
2% BSA in CB  BSA Fisher Bio Reagents 
CAS 9048-46-
8 
Washing 2% BSA and 0.2% Tween® 20 in CB Fisher Scientific  CAS 9005-64-5 
Secondary 
Dilution 
Alexa Fluor® 488 Goat Anti-Rabbit 
IgG 
Life Technologies A-11029 
WhatmanTM Chromatography Paper NuPAGE® 3030-6188 
Texas Red®-X Phalloidin  Life Technologies   T7471 
NucBlue® Live ReadyProbes® 
Reagent Life Technologies  R37605 
 2% BSA in CB  BSA Fisher Bio Reagents 
CAS 9048-46-
8 
Mounting Prolong® Gold Antifade Mountant  Life Technologies  P36934 
 
Part 1: Immunofluorescence solution recipe 
Cytoskeletal Buffer 
1. Add compounds into a 500 mL flask 
• 150 mM NaCl 
• 10 mM MES 
• 5 mM MgCl2 
• 5 mM EGTA 5 mM glucose 
• 400 mL ddH2O 
 
2. Adjust pH the buffer to 6.1 with NaOH.  
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Table 6. Primary antibodies dilutions for IF 
Primary Antibody Blocking Solution Antibody Concentration 
CD31 BSA in CB 1:500 
SM22-α BSA in CB 1:500 
VE-Cadherin BSA in CB 1:750 
Vimentin BSA in CB 1:750 
 
Table 7. Secondary antibodies dilutions for IF 
Secondary Antibody Primary Antibodies Targeted  
Secondary Antibody 
Concentration  
Goat anti-Mouse IgG 
488 
VE-Cad 1:500 Vimentin 
Goat anti-Rabbit IgG 
647 
CD31 1:500 SM22-α 
Texas Red®-X 
Phalloidin F-actin 1:200 
NucBlue® Live 
ReadyProbes® 
Reagent 
Nucleus 2 drops /mL 
 
 
